Modeling of aniridia-related keratopathy by CRISPR/Cas9 genome editing of human limbal epithelial cells and rescue by recombinant PAX6 protein

被引：0
|
作者：
Aberdam, D. [1 ]
机构：
[1] Stem Cells & Physiopathol Hop St Louis, INSERM, U976, Paris, France
来源：
ACTA OPHTHALMOLOGICA | 2018年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3364
引用
收藏
页码：111 / 111
页数：1
相关论文
共 50 条
  • [21] A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells
    Geng, Bing-chuan
    Choi, Kyoung-Han
    Wang, Shan-zhi
    Chen, Peng
    Pan, Xiu-di
    Dong, Nian-guo
    Ko, Jae-Kyun
    Zhu, Hua
    ACTA PHARMACOLOGICA SINICA, 2020, 41 (11) : 1427 - 1432
  • [22] A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells
    Bing-chuan Geng
    Kyoung-Han Choi
    Shan-zhi Wang
    Peng Chen
    Xiu-di Pan
    Nian-guo Dong
    Jae-Kyun Ko
    Hua Zhu
    Acta Pharmacologica Sinica, 2020, 41 : 1427 - 1432
  • [23] CRISPR/Cas9 Genome-Editing System in Human Stem Cells: Current Status and Future Prospects
    Zhang, Zhao
    Zhang, Yuelin
    Gao, Fei
    Han, Shuo
    Cheah, Kathryn S.
    Tse, Hung-Fat
    Lian, Qizhou
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2017, 9 : 230 - 241
  • [24] Accelerated Apoptosis and Down-Regulated FMRP in Human Neuroblastoma Cells with CRISPR/Cas9 Genome Editing
    Zhang, Rong
    Xu, Huifen
    Lu, Jin
    Chen, Ying
    Zhang, Yahui
    Xiao, Li
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2023, 52 (04) : 703 - 712
  • [25] Highly efficient biallelic genome editing of human ES/iPS cells using a CRISPR/Cas9 or TALEN system
    Takayama, Kazuo
    Igai, Keisuke
    Hagihara, Yasuko
    Hashimoto, Rina
    Hanawa, Morifumi
    Sakuma, Tetsushi
    Tachibana, Masashi
    Sakurai, Fuminori
    Yamamoto, Takashi
    Mizuguchi, Hiroyuki
    NUCLEIC ACIDS RESEARCH, 2017, 45 (09) : 5198 - 5207
  • [26] Modeling Wnt signaling by CRISPR-Cas9 genome editing recapitulates neoplasia in human Barrett epithelial organoids
    Liu, Xi
    Cheng, Yulan
    Abraham, John M.
    Wang, Zhixiong
    Wang, Zhe
    Ke, Xiquan
    Yan, Rong
    Shin, Eun Ji
    Ngamruengphong, Saowanee
    Khashab, Mouen A.
    Zhang, Guanjun
    McNamara, George
    Ewald, Andrew J.
    Lin, DeChen
    Liu, Zhengwen
    Meltzer, Stephen J.
    CANCER LETTERS, 2018, 436 : 109 - 118
  • [27] CRISPR/Cas9-mediated gene-editing of TAPBP to alleviate antigenicity of human corneal-limbal epithelial cells
    Scapin, Giorgia
    Chauhan, Sunil
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [28] CRISPR/Cas9 genome editing in human pluripotent stem cell-cardiomyocytes provides a platform for modeling hypertrophic cardiomyopathy
    Mosqueira, D.
    Mannhardt, I.
    Bhagwan, J. R.
    Lis-Slimak, K.
    Katili, P.
    Scott, E.
    Hassan, M.
    Prondzynski, M.
    Harmer, S.
    Tinker, A.
    Smith, J. G. W.
    Carrier, L.
    Williams, P.
    Gaffney, D.
    Eschenhagen, T.
    Hansen, A.
    Denning, C.
    HUMAN GENE THERAPY, 2019, 30 (02) : A5 - A5
  • [29] Ultra-deep sequencing validates safety of CRISPR/Cas9 genome editing in human hematopoietic stem and progenitor cells
    Cromer, M. Kyle
    Barsan, Valentin V.
    Jaeger, Erich
    Wang, Mengchi
    Hampton, Jessica P.
    Chen, Feng
    Kennedy, Drew
    Xiao, Jenny
    Khrebtukova, Irina
    Granat, Ana
    Truong, Tiffany
    Porteus, Matthew H.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [30] Ultra-deep sequencing validates safety of CRISPR/Cas9 genome editing in human hematopoietic stem and progenitor cells
    M. Kyle Cromer
    Valentin V. Barsan
    Erich Jaeger
    Mengchi Wang
    Jessica P. Hampton
    Feng Chen
    Drew Kennedy
    Jenny Xiao
    Irina Khrebtukova
    Ana Granat
    Tiffany Truong
    Matthew H. Porteus
    Nature Communications, 13
12345